List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 952 studies with search of:   Czech Republic
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Natalizumab
2 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
3 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
4 Completed Efficacy and Safety of BG00012 in MS
Condition: Multiple Sclerosis
Intervention: Drug: BG00012
5 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
6 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
7 Completed Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Condition: Cardiovascular Disease
Intervention: Drug: atorvastatin
8 Recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
9 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
10 Completed Comparative Atorvastatin Pleiotropic Effects
Conditions: Coronary Arteriosclerosis;   Hypercholesterolemia
Interventions: Procedure: Blood samples;   Drug: Atorvastatin
11 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
12 Recruiting Randomized,Multicentric Study to Treat Prolapse After Hysterectomy With Amreich Procedure or Total Prolift Procedure
Condition: Pelvic Organ Prolapse
Interventions: Procedure: Vaginal fixation Amreich-Richter;   Procedure: Prolift total
13 Recruiting Study of Non-Small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-Based Treatment
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib (Tarceva®, OSI Pharmaceuticals, Inc, Hoffman-La Roche, Genentech, Inc);   Drug: Pralatrexate Injection
14 Recruiting The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With CKD Stage 5
Conditions: Chronic Kidney Disease Stage 5;   Left Ventricular Hypertrophy
Interventions: Drug: paricalcitol injection;   Drug: placebo injection
15 Completed Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: GW679769;   Drug: Dexamethasone;   Drug: Ondansetron Hydrochloride
16 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin
17 Recruiting A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
Conditions: Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Non-Hodgkin
Interventions: Drug: SGN-40;   Drug: placebo;   Drug: rituximab;   Drug: etoposide;   Drug: carboplatin;   Drug: ifosfamide
18 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
19 Recruiting Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 mg;   Drug: Placebo
20 Completed RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services